The diagnosis of endometriosis takes too long, especially for young women. While symptoms often appear in the teens or early twenties, diagnosis typically occurs much later, between 25-35. Aside from the factors leading to diagnostic delays in adults, there are further factors contributing to the delay in young women.

Endometriosis in young women is often unrecognized by family members and even healthcare providers. Painful periods are often dismissed as “normal”, leading girls to suffer in silence.

Endometriosis presents differently in young women and can be missed by inexperienced doctors. Doctors may be hesitant to perform laparoscopy on young patients, opting for "watchful waiting" instead.

The longer it takes to diagnose and treat endometriosis, the greater the negative impact. We need to raise awareness of endometriosis in young women and encourage earlier diagnosis.

Gesynta Pharma is dedicated to the development of better treatments for endometriosis patients, with promising preclinical data for vipoglanstat and a phase II study coming.